Nicotinic acid receptor abnormalities in human skin cancer: Implications for a role in epidermal differentiation

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Bermudez, Yira ^a   Benavente, Claudia A ^a   Meyer, Ralph G ^a   Coyle, W Russell ^a   Jacobson, Myron K ^a   Jacobson, Elaine L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 14; FILAGGRIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 109A; G PROTEIN COUPLED RECEPTOR 109B; NICOTINIC ACID RECEPTOR; UNCLASSIFIED DRUG; CYCLIC AMP; GPR109A PROTEIN, HUMAN; GPR109B PROTEIN, HUMAN; NICOTINIC ACID; NICOTINIC RECEPTOR;

ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPIDERMIS; EPIDERMIS CELL; GENE EXPRESSION; GPR109A GENE; GPR109B GENE; HAIR FOLLICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PROTEIN EXPRESSION; SKIN CANCER; SKIN FIBROBLAST; SQUAMOUS CELL CARCINOMA; CELL CULTURE; CELL LINE; DRUG EFFECT; GENETICS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SKIN TUMOR; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE; CELLS, CULTURED; CYCLIC AMP; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; NIACIN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; SKIN NEOPLASMS;

EID: 79957817724     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020487     Document Type: Article

References (26)

1. Fuchs E, (2007) Scratching the surface of skin development. Nature 445: 834-842.
2. Trautinger F, (2001) Mechanisms of photodamage of the skin and its functional consequences for skin ageing. Clin Exp Dermatol 26: 573-577.
3. Lever W, Schaumberg-Lever G, (1983) Histopathology of the Skin: JB Lippincott New York.
4. Mudgil AV, Segal N, Andriani F, Wang Y, Fusenig NE, et al. (2003) Ultraviolet B irradiation induces expansion of intraepithelial tumor cells in a tissue model of early cancer progression. J Invest Dermatol 121: 191-197.
5. Jacobson EL, Kim H, Kim M, Williams JD, Coyle DL, et al. (2007) A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. Exp Dermatol 16: 490-499.
6. Soga T, Kamohara M, Takasaki J, Matsumoto S, Saito T, et al. (2003) Molecular identification of nicotinic acid receptor. Biochem Biophys Res Commun 303: 364-369.
7. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, et al. (2003) PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9: 352-355.
8. Wise A, Foord SM, Fraser NJ, Barnes AA, Elshourbagy N, et al. (2003) Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 278: 9869-9874.
9. Offermanns S, (2006) The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends Pharmacol Sci 27: 384-390.
10. Benyo Z, Gille A, Kero J, Csiky M, Suchankova MC, et al. (2005) GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 115: 3634-3640.
11. Richman JG, Kanemitsu-Parks M, Gaidarov I, Cameron JS, Griffin P, et al. (2007) Nicotinic acid receptor agonists differentially activate downstream effectors. J Biol Chem 282: 18028-18036.
12. Maciejewski-Lenoir D, Richman JG, Hakak Y, Gaidarov I, Behan DP, et al. (2006) Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol 126: 2637-2646.
13. Benyo Z, Gille A, Bennett CL, Clausen BE, Offermanns S, (2006) Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. Mol Pharmacol 70: 1844-1849.
14. Walters RW, Shukla AK, Kovacs JJ, Violin JD, DeWire SM, et al. (2009) beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J Clin Invest 119: 1312-1321.
15. Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA, Fusenig NE, (1990) c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res 50: 2840-2847.
16. Gibson UE, Heid CA, Williams PM, (1996) A novel method for real time quantitative RT-PCR. Genome Res 6: 995-1001.
17. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
18. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
19. Rowert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, et al. (2007) Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 156 (Suppl 3): 8-12.
20. Denecker G, Hoste E, Gilbert B, Hochepied T, Ovaere P, et al. (2007) Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 9: 666-674.
21. Tang H, Lu JY, Zheng X, Yang Y, Reagan JD, (2008) The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist. Biochem Biophys Res Commun.
22. Gille A, Bodor ET, Ahmed K, Offermanns S, (2008) Nicotinic acid: pharmacological effects and mechanisms of action. Annu Rev Pharmacol Toxicol 48: 79-106.
23. Digby JE, Lee JM, Choudhury RP, (2009) Nicotinic acid and the prevention of coronary artery disease. Curr Opin Lipidol 20: 321-326.
24. Gensler HL, Williams T, Huang AC, Jacobson EL, (1999) Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice. Nutr Cancer 34: 36-41.
25. Zhou L, Tang Y, Cryan EV, Demarest KT, (2007) Human epidermoid A431 cells express functional nicotinic acid receptor HM74a. Mol Cell Biochem 294: 243-248.
26. Thangaraju M, Carswell KN, Prasad PD, Ganapathy V, (2009) Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem J 417: 379-389.